JPS5959625A - ガン壊死因子を安定化する方法 - Google Patents

ガン壊死因子を安定化する方法

Info

Publication number
JPS5959625A
JPS5959625A JP57172178A JP17217882A JPS5959625A JP S5959625 A JPS5959625 A JP S5959625A JP 57172178 A JP57172178 A JP 57172178A JP 17217882 A JP17217882 A JP 17217882A JP S5959625 A JPS5959625 A JP S5959625A
Authority
JP
Japan
Prior art keywords
tnf
solution
present
activity
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP57172178A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0314291B2 (enrdf_load_stackoverflow
Inventor
Masanobu Komiya
小宮　雅信
Hiroshi Hayashi
林　紘
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Corp
Asahi Chemical Industry Co Ltd
Sumitomo Pharma Co Ltd
Original Assignee
Dainippon Pharmaceutical Co Ltd
Asahi Chemical Industry Co Ltd
Asahi Kasei Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co Ltd, Asahi Chemical Industry Co Ltd, Asahi Kasei Kogyo KK filed Critical Dainippon Pharmaceutical Co Ltd
Priority to JP57172178A priority Critical patent/JPS5959625A/ja
Priority to US06/524,540 priority patent/US4457916A/en
Priority to IT67886/83A priority patent/IT1200970B/it
Priority to DE3331003A priority patent/DE3331003C2/de
Priority to ES525228A priority patent/ES8706446A1/es
Priority to FR8313971A priority patent/FR2532178B1/fr
Priority to GB08323271A priority patent/GB2126588B/en
Publication of JPS5959625A publication Critical patent/JPS5959625A/ja
Publication of JPH0314291B2 publication Critical patent/JPH0314291B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP57172178A 1982-08-31 1982-09-28 ガン壊死因子を安定化する方法 Granted JPS5959625A (ja)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP57172178A JPS5959625A (ja) 1982-09-28 1982-09-28 ガン壊死因子を安定化する方法
US06/524,540 US4457916A (en) 1982-08-31 1983-08-19 Method for stabilizing Tumor Necrosis Factor and a stable aqueous solution or powder containing the same
IT67886/83A IT1200970B (it) 1982-08-31 1983-08-23 Procedimento per stabilizzare un fattore avente effetto necrotizzante sui tumori e soluzione aquosa stabile o polvere che lo contiene
DE3331003A DE3331003C2 (de) 1982-08-31 1983-08-27 Verfahren zur Stabilisierung des Tumor-Nekrose-Faktors und diesen enthaltende wäßrige Lösung oder Pulversubstanz
ES525228A ES8706446A1 (es) 1982-08-31 1983-08-30 Un metodo para preparar una solucion acuosa estable que contiene factor de necrosis de tumores.
FR8313971A FR2532178B1 (fr) 1982-08-31 1983-08-31 Procede pour stabiliser le facteur de necrose tumorale et solution aqueuse ou poudre stables contenant ce facteur
GB08323271A GB2126588B (en) 1982-08-31 1983-08-31 A method for stabilizing tumor necrosis factor and a stable aqueous solution or powder containing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57172178A JPS5959625A (ja) 1982-09-28 1982-09-28 ガン壊死因子を安定化する方法

Publications (2)

Publication Number Publication Date
JPS5959625A true JPS5959625A (ja) 1984-04-05
JPH0314291B2 JPH0314291B2 (enrdf_load_stackoverflow) 1991-02-26

Family

ID=15937016

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57172178A Granted JPS5959625A (ja) 1982-08-31 1982-09-28 ガン壊死因子を安定化する方法

Country Status (1)

Country Link
JP (1) JPS5959625A (enrdf_load_stackoverflow)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0166996A1 (en) 1984-06-07 1986-01-08 Asahi Kasei Kogyo Kabushiki Kaisha A method for stabilizing a physiologically active substance produced by recombinant DNA technique and a stable aqueous solution or powder containing the same
JPS62501562A (ja) * 1985-02-01 1987-06-25 ニユ−ヨ−ク　ユニバ−シイテイ 抗血友病因子の精製方法
JPS63146827A (ja) * 1986-07-18 1988-06-18 Chugai Pharmaceut Co Ltd 安定な顆粒球コロニ−刺激因子含有製剤
US5026772A (en) * 1987-09-01 1991-06-25 Yamanouchi Pharmaceutical Co., Ltd. Lyophilized pharmaceutical composition of neocarzinostatin derivative
JP2004256545A (ja) * 2000-02-08 2004-09-16 Allergan Inc ボツリヌス毒素医薬組成物

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0166996A1 (en) 1984-06-07 1986-01-08 Asahi Kasei Kogyo Kabushiki Kaisha A method for stabilizing a physiologically active substance produced by recombinant DNA technique and a stable aqueous solution or powder containing the same
EP0166996B2 (en) † 1984-06-07 1994-12-21 Asahi Kasei Kogyo Kabushiki Kaisha A method for stabilizing a physiologically active substance produced by recombinant DNA technique and a stable aqueous solution or powder containing the same
JPS62501562A (ja) * 1985-02-01 1987-06-25 ニユ−ヨ−ク　ユニバ−シイテイ 抗血友病因子の精製方法
JPS63146827A (ja) * 1986-07-18 1988-06-18 Chugai Pharmaceut Co Ltd 安定な顆粒球コロニ−刺激因子含有製剤
US5026772A (en) * 1987-09-01 1991-06-25 Yamanouchi Pharmaceutical Co., Ltd. Lyophilized pharmaceutical composition of neocarzinostatin derivative
JP2004256545A (ja) * 2000-02-08 2004-09-16 Allergan Inc ボツリヌス毒素医薬組成物

Also Published As

Publication number Publication date
JPH0314291B2 (enrdf_load_stackoverflow) 1991-02-26

Similar Documents

Publication Publication Date Title
US4061537A (en) Polyionic isotonic salt solution
EP0091258B2 (en) Method for stabilizing tumor necrosis factor and a stable aqueous solution or powder containing said factor
US4457916A (en) Method for stabilizing Tumor Necrosis Factor and a stable aqueous solution or powder containing the same
JPS60258125A (ja) 蛋白性生理活性物質を含有する水溶性乾燥物
DE69829605T2 (de) Chondroitinase enthaltende Zusammensetzungen
Askonas A study on globulin formation by plasma-cell neoplasm (5563) transplantable in mice
EP0123291A2 (en) Method for stabilizing interferon
JPS589688A (ja) 安定な酵素組成物
EP0123304A2 (en) A method for stabilizing tissue plasminogen activator and a stable aqueous solution or powder containing the same
KR980008241A (ko) 저 당 함량을 가지는 안정한 알부민 무함유 재조합 인자 ⅷ의 제제
CN103402526B (zh) 组蛋白抑制
US3864478A (en) Storage-stable hemoglobin solutions and method for their preparation
US4062933A (en) Colloidal compositions with protective agents suitable for radioactive labeling
Buecher Jr et al. Ficoll activation of a protein essential for maturation of the free-living nematode Caenorhabditis briggsae.
野口敏 et al. Studies on the control of denaturation of fish muscle proteins during frozen storage. VI. Preventive effect of carbohydrates.
JPS5959625A (ja) ガン壊死因子を安定化する方法
GB2221907A (en) Superoxide dismutase composition.
JPH0375529B2 (enrdf_load_stackoverflow)
JP3522798B2 (ja) 糖修飾蛋白質の製造法
JPH0375530B2 (enrdf_load_stackoverflow)
JPH04198195A (ja) Ｃｐｂ―ｉの安定化方法及び製剤組成物
Rybicka Glycosomes (protein-glycogen complex) in the canine heart: Ultrastructure, histochemistry and changes induced by acidic treatment
JPS6059000A (ja) インタ−フェロンの安定化方法
JPS5939829A (ja) ガン壊死因子安定化法
DE1617279A1 (de) Verfahren zur Herstellung pharmazeutischer Praeparate zur Verhinderung der Bildung von Blutgerinnseln